Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

745 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognosis of COVID-19 severity using DERGA, a novel machine learning algorithm.
Asteris PG, Gandomi AH, Armaghani DJ, Kokoris S, Papandreadi AT, Roumelioti A, Papanikolaou S, Tsoukalas MZ, Triantafyllidis L, Koutras EI, Bardhan A, Mohammed AS, Naderpour H, Paudel S, Samui P, Ntanasis-Stathopoulos I, Dimopoulos MA, Terpos E. Asteris PG, et al. Among authors: terpos e. Eur J Intern Med. 2024 Mar 7:S0953-6205(24)00094-3. doi: 10.1016/j.ejim.2024.02.037. Online ahead of print. Eur J Intern Med. 2024. PMID: 38458880
Serum concentrations of angiogenic cytokines in Waldenstrom macroglobulinaemia: the ration of angiopoietin-1 to angiopoietin-2 and angiogenin correlate with disease severity.
Anagnostopoulos A, Eleftherakis-Papaiakovou V, Kastritis E, Tsionos K, Bamias A, Meletis J, Dimopoulos MA, Terpos E. Anagnostopoulos A, et al. Among authors: terpos e. Br J Haematol. 2007 Jun;137(6):560-8. doi: 10.1111/j.1365-2141.2007.06609.x. Br J Haematol. 2007. PMID: 17451406 Free article.
Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone.
Kastritis E, Anagnostopoulos A, Roussou M, Toumanidis S, Pamboukas C, Migkou M, Tassidou A, Xilouri I, Delibasi S, Psimenou E, Mellou S, Terpos E, Nanas J, Dimopoulos MA. Kastritis E, et al. Among authors: terpos e. Haematologica. 2007 Oct;92(10):1351-8. doi: 10.3324/haematol.11325. Haematologica. 2007. PMID: 18024372 Free article. Clinical Trial.
Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration.
Terpos E, Katodritou E, Tsiftsakis E, Kastritis E, Christoulas D, Pouli A, Michalis E, Verrou E, Anargyrou K, Tsionos K, Dimopoulos MA, Zervas K; Greek Myeloma Study Group. Terpos E, et al. Haematologica. 2009 Mar;94(3):372-9. doi: 10.3324/haematol.2008.000638. Haematologica. 2009. PMID: 19252175 Free PMC article. Clinical Trial.
745 results